路暢科技(002813.SZ):擬向銀行等金融機構申請5億元綜合授信額度
格隆匯4月12日丨 路暢科技(002813.SZ)公佈,公司因經營發展需要,擬向銀行等金融機構申請人民幣5億元的綜合授信額度(敞口部分不超過5億元)。
綜合授信額度包括但不限於流動資金借款、銀行承兑匯票、票據貼現、貿易融資、信用證、保函等。公司擬對本次申請綜合授信額度及額度範圍內的貸款、開立保函及其他業務等提供信用擔保或以公司自有資產進行抵押擔保。最終授信額度、授信期限、擔保方式、擔保期限以公司與金融機構簽訂的協議為準。
以上綜合授信額度不等於公司的實際融資金額,具體合作金融機構及最終融資金額、形式後續將與有關機構進一步協商確定,以正式簽署的協議或合同為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.